Breadcrumb
WIRB-Copernicus Group (WCG)
When relying on an external or centralized IRB of record, it is the Principal Investigator’s responsibility to adhere to policies and procedures of the IRB of record. However, the Principal Investigator must also follow all University of Iowa (UI) institutional policies, as well as state and local laws governing human subjects research. The HawkIRB application captures information needed for UI HRPP Committee review and to ensure compliance with institutional policies.
If you are interested in utilizing an External IRB model, please review the "Final SOP for General External IRB" for specific information on the process and contact the Human Subjects Office at uirb-external@uiowa.edu. We will help you determine which model may work best for your proposal (Lead IRB of record, Relying IRB, commercial IRB models, etc.)
General Submission Information
The UI has contracted with the WIRB-Copernicus Group (WCG) for the option of review and oversight of new industry-initiated and industry-sponsored protocols that meet certain criteria. UI researchers have the option to submit the study to the UI IRB.
Studies must be submitted to WCG automatically if the following condition(s):
- The study has funding from DOD Navy (Department of Defense) and requires the institution to sign a DOD addendum to the UI FWA.
Studies may be submitted to WCG if they meet the following conditions:
- The study involves human subjects and is designed to prospectively evaluate the safety and/or effectiveness of new drugs, devices, or behavioral interventions.
- The protocol was designed and written by the sponsor.
- The sponsor holds all Investigational New Drug (IND) applications for the protocol.
- The only sponsor is a for-profit entity/company.
- The UI investigator has not previously submitted the study to a UI IRB.
- The project does NOT involve any of the following:
- Xenotransplantation
- Embryonic stem cells
Note: The UI reserves the right to retain IRB oversight of any new research protocol, regardless of industry sponsorship, and prevent it from being sent to WCG for review. For those studies that are retained by the UI IRB, there are associated IRB fees.
- Federally-Funded Studies: Although this falls outside of our Master Service Agreement with WCG, the UI allows studies with federal funding to seek oversight by WCG. Therefore, a separate reliance agreement must be sought between UI and WCG on a case-by-case basis when studies seeking oversight with WCG have federal funding. The Commercial IRB Coordinator is responsible for initiating this reliance agreement. To submit a federally funded study to WCG, see details below.
- Unique situations: The UI IRB may direct studies to submit to WCG if the IRB has concerns whether it possesses the appropriate expertise or resources to provide proper oversight of a study. Please consult with the Commercial Coordinator for additional guidance in these unique situations.
- VA Health Care System (VAHCS) Studies: The VAHCS does not currently accept commercial IRB review unless special approval is received from the VA Office of Research and Development (ORD). Therefore, projects conducted at the Iowa City VAHCS may not be reviewed by WCG. They must be reviewed by IRB-03. This includes projects which propose the use of Veteran's Administration facilities, equipment, or patients. Full-time VA employees may not be involved as PI, Co-I, or Sub-I in any project submitted to WCG without prior VA approval.
WCG Policies & Procedures
The information provided below is to assist UI investigators with the UI/WCG process for submission of applications.
WCG Submission Process
- UI HawkIRB application for New Protocol Submissions to WCG
- Select the WIRB-Copernicus Group, Inc. (WCG) (formerly known as WIRB) in question I.1. Any non-industry funding source will require a separate reliance agreement.
- Enter Study Team members (Section II) of the application.
- A current eCOI disclosure is required.
- Enter the funding source (Section III), if any.
- Answer the question about financial conflicts of interest.
- Project Materials Check. This page allows the user to submit the application without attaching required documentation in order to generate an IRB number. Please Note: Users will still need to return the application to the HSO with all required attachments (protocol, consent document, other HRPP-related committee review materials, etc.) in order to obtain institutional signoff for the WCG submission. Other Committee review also will not begin until the project form has been routed back to the HSO.
- Project Type (Section IV). Indicate whether or not the study will follow full ICH-GCP standards. This selection is required only if the sponsor has indicated they are not willing to agree to ICH-GCP as per the FDA regulations.
- Other Committee Review (Section V). Effective June 2024, the WCG Coordinator can grant permission to submit to WCG even if all HRPP committees are still pending. HRPP committee approvals must be finalized before the institutional hold with WCG is lifted and the study is released in HawkIRB: :
- Pharmacy and Therapeutics Committee (P&T)
- Pharmacy and Therapeutics (P&T) Investigational Drug Device (IDS) - studies involving approved or investigational drugs with a focus on drug disbursement, storage, preparation and inventory control.
- Medical Radiation Protection Committee (MRPC)
- Institutional Biosafety Committee (IBC)
- Clinical Research Unit (CRU)
- Holden Comprehensive Cancer Center (PRMC)
- UIHC Research Billing Compliance (RBC)
- Nursing Research Committee (NRC)
- Division of Sponsored Programs (DSP)
- Pharmacy and Therapeutics Committee (P&T)
- Subject information, including the recruitment of prisoners (Section VI)
- Project Description (Section VII), including:
- Location of research activities
- Use of registries, repositories, type of study, etc.
- Protocol details
- Recruitment requiring local context review, i.e., mass email
- Compensation
- ROC- Record of Consent (University of Iowa Health Care policy IM-MR-06.21 titled, "Documentation of patient participation as a subject in a research protocol or use of an investigational medication, study medication, investigational device, or biologic.")
- The final section is for Attachments. Attachments should include:
- Consent Document (created from the template generated in Hawk IRB in the Application section)
- A copy of the protocol
- A copy of your draft WCG IRB application
- Once a Hawk IRB application has been submitted to the HSO for review, all required other UI Committees will receive a notification that its review is required. After the HSO has reviewed the Hawk IRB Application in its entirety and determined all UI requirements are being met, the Institutional Approval Memo will be attached to the application.
- Submit the application to WCG. (You must include the HSO Institutional Approval Memo in your submission in order for WCG to review your application.)
- Log into Connexus to complete the new smartform application. Any questions during the WCG submission process should be directed to WCG at clientservices@wirb.com or 1-800-562-4789.
Informed Consent Documents for WCG: Best Practices
New Projects
- Obtain the WCG-approved template consent for the "protocol level" (overall study approval).
- Track in University of Iowa required language into the WCG-approved template consent ensuring "tracked changes" are turned on. Ensure the site/sponsor does not turn off tracked changes or "accept" changes during review. All changes to the template must be shown as "tracked changes" when submitting to WCG.
- University of Iowa language could include the following. Most language is included in the downloadable informed consent template during creation of your HawkIRB application, with exception of committee-specific language:
- Add HawkIRB number within the title page (Ex: Institutional Number: 202512345)
- HIPAA section (Authorization to use and disclose information for research purposes) (Institutional policy)
- Compensation for Injury (Institutional policy)
- SSN collection: for compensation purposes (if compensation if greater than $100 per payment or $600 or more in a calendar year) (IRS regulations/Grant Accounting Policy)
- SSN collection for any other reason is required by the University to be disclosed in the consent
- Legally Authorized Representative (LAR) order of authority list (Iowa law/Institutional policy)
- Pregnancy testing for females under the age of 18 (UIHC policy)
- HIV/Hepatitis reporting requirements (Iowa law)
- Medical Radiation Protection Committee required changes outlined in the eMRPC form (Institutional policy)
- Note: Institutional committees and the Human Subjects Office reserve the right to require changes outside of the items listed above
- University of Iowa language could include the following. Most language is included in the downloadable informed consent template during creation of your HawkIRB application, with exception of committee-specific language:
- Once this is complete, upload this version to the "Tracked Change" Consent Document category within the HawkIRB application for HSO review
- Note: It is preferred the HSO reviews your consent documents in HawkIRB PRIOR to sending to the sponsor so the HSO reviewer can verify all required changes are incorporated when to sending on to the sponsor. This reduces confusion and unnecessary back and forth with the sponsor.
- Once all workflow is addressed within the HawkIRB application, an "external IRB exception memo" will be issued for the study approving it to be submitted to the external IRB. When submitting consent forms, please submit the most recent tracked change versions that have been negotiated in HawkIRB.
Modifications
Sponsored-initiated changes
Sponsors typically submit consent form changes on the "protocol level" when the changes affect all sites. Once approved at this level, modifications are typically automatically created for sites. WCG will send an email to the PI and all team contacts with the tracked changes version of the protocol level template stating:
"Due to the policies established between the Institution and WCG IRB, please note that the request to review the information for this investigator has been withdrawn, but will resume processing once the site has sent to WCG IRB a request for review of the information outlined above. "
The University of Iowa has an agreement with WCG IRB that new consent documents must have site approval to continue processing. When this notice is received you can do one of two things:
- Review the tracked changes version of the protocol level template, verify that none of the changes affect UI language or HRPP committee reviews. If this is true, you can reply to this email from WCG stating the modification can resume processing. WCG will then apply the tracked changes to the site-level consent and contact the HSO if any of the language deviates from the University of Iowa template language on file. This is typically the better option when the tracked changes do not affect any local requirements and the research team does not require any additional changes outside of what is outlined in the tracked changes.
- Download the most recent clean approved version of the consent from WCG Connexus, make the tracked changes shown in the version of the protocol level template WCG sent in their email, and respond to their email attaching the version created. This is typically the better option when the team needs to make changes outside of the changes outlined in the protocol level template. Examples below:
- Local contact information updates
- Changes prompt UI-required template language
- New changes add an LAR signature line, therefore prompting UI and state law LAR language
- Sponsor adds an entity to the consent they will be sharing PHI with therefore prompting changes to the second paragraph of the UI HIPAA section
OR
- Once WCG has fully approved the consent modification, submit this as a modification to HawkIRB.
Site-initiated changes
- Download the most recent approved version of the consent from WCG Connexus.
- Make any tracked changes necessary.
- Initiate a modification in WCG Connexus for the study and submit for approval
- Once WCG has fully approved the modification, create a HawkIRB modification for the study implementing the changes and submit the modification to the HSO
Additional Considerations:
- This process could differ between sponsors. Please communicate with the sponsor of your research project how they will handle sponsor-initiated changes.
- The research team is responsible for understanding when UI required language and UI HRPP reviews may apply to their research. For example, changes like adding a new consent form, study arm/cohort additions or new risks may require approval from one or more UI HRPP committees. A modification can be submitted in HawkIRB for these items to be reviewed prior to submitting to the commercial IRB. This reduces the number of back-and-forth submissions that can occur either between the site and sponsor, or the site and the commercial IRB. To do this, answer "No" to EXT.2 to indicate the changes are not yet approved by the commercial IRB
- Upload the tracked changes versions of the consents and any other necessary updates that apply to the changes
- Properly answer the questions in XIV to trigger committee reviews. Once committee reviews are completed and the committees have approved the consent with or without changes, follow the instructions above to continue processing the modification with the commercial IRB.
- Once the commercial IRB approves new consent documents or materials, those materials should be used immediately. Do not wait until HawkIRB has approved new materials to use new IRB-approved materials, this could lead to non-compliance.
- Please submit modifications in HawkIRB for required Post-Approval Submissions as soon as possible to notify the HSO and HRPP of any changes to the research. There are institutional requirements to update the institution’s research system in a timely manner when using an External IRB of Record. Not submitting required updates in HawkIRB could affect the funding and clinical trial status if not updated in a timely manner.
WCG Review Process and Approval Notification
- Submission to WCG: The study team will submit their application to WCG after receiving the “Approval to Submit” memo in HawkIRB. The team will ensure the most updated consents, “Approval to Submit” memo, and any other updated documents are submitted with the application to WCG.
- Approval from WCG: WCG will notify the Human Subjects Office (HSO) and the study team when the new project application is approved via email. WCG is now the IRB of record for the protocol.
- Institutional Hold Pending Committee Reviews: Studies cannot begin until all UI committees complete their review, therefore WCG places an institutional hold on approved documents until the HSO confirms all approvals are in place at UI.
- Return Project in HawkIRB Upon Notification of WCG Approval: Once WCG approves the study at a site level, the team is responsible for returning the application in HawkIRB to the HSO.
- HSO Final Review: The WCG Coordinator verifies that the UI template language in the Informed Consent Document is correct, confirms a Partial HIPAA is granted by WCG if applicable, and verifies all approval documents are correct.
- Institution Hold Release: After a final review of the documents approved by WCG, the WCG Coordinator will then notify WCG to release the institutional hold on the approval documents. WCG typically releases the approval documents to the research team within two business days from the UI notification.
- WCG Notification to PI of Institutional Hold Release: The PI will receive copies of all regulatory documents and approved consent forms from WCG.
- HawkIRB Approval and Release: The WCG Coordinator will attach the WCG Approval Memo documentation in HawkIRB and release the project to the PI.
- Full Approval: Research may begin once the WCG approved materials have been received by the Principal Investigator.
Please note: The UI IRB Compliance Program may monitor any WCG-approved protocols.
Post-Approval Submission Requirements
For post-approval submission requirements, click here.
Contact Information
Contact WCG with any questions regarding WCG procedures or forms:
Phone: 800-562-4789
Fax: 360-252-2498
Email: clientservices@wirb.com
Mail: 1019 39th Avenue SE, Suite 120 Puyallup, WA 98374-2115
Contact the University of Iowa's Commercial Coordinator in the Human Subjects Office with questions regarding the application process or UI requirements:
Mayzie Tucker
Phone: 319-467-4182
Fax: 319-335-7310
Email: uiwirb@uiowa.edu
Mail: 105A HLHS, Human Subjects Office, University of Iowa, 600 Newton Rd Iowa City, IA 52242
Last updated 9/3/25